Immunovant, Inc. (IMVT)

26.18 +0.37 (+1.43%) USD  |  NASDAQ  |  Jan 13, 16:00
26.22 +0.04 (+0.15%) Pre-Market: 09:00
More

Immunovant Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for IMVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Revvity, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade